Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Frataxin deficiency lowers lean mass and triggers the integrated stress response in skeletal muscle
César Vásquez-Trincado, Julia Dunn, Ji In Han, Briyanna Hymms, Jaclyn Tamaroff, Monika Patel, Sara Nguyen, Anna Dedio, Kristin Wade, Chinazo Enigwe, Zuzana Nichtova, David R. Lynch, Gyorgy Csordas, Shana E. McCormack, Erin L. Seifert
César Vásquez-Trincado, Julia Dunn, Ji In Han, Briyanna Hymms, Jaclyn Tamaroff, Monika Patel, Sara Nguyen, Anna Dedio, Kristin Wade, Chinazo Enigwe, Zuzana Nichtova, David R. Lynch, Gyorgy Csordas, Shana E. McCormack, Erin L. Seifert
View: Text | PDF
Research Article Muscle biology

Frataxin deficiency lowers lean mass and triggers the integrated stress response in skeletal muscle

  • Text
  • PDF
Abstract

Friedreich’s ataxia (FRDA) is an inherited disorder caused by reduced levels of frataxin (FXN), which is required for iron-sulfur cluster biogenesis. Neurological and cardiac comorbidities are prominent and have been a major focus of study. Skeletal muscle has received less attention despite indications that FXN loss affects it. Here, we show that lean mass is lower, whereas body mass index is unaltered, in separate cohorts of adults and children with FRDA. In adults, lower lean mass correlated with disease severity. To further investigate FXN loss in skeletal muscle, we used a transgenic mouse model of whole-body inducible and progressive FXN depletion. There was little impact of FXN loss when FXN was approximately 20% of control levels. When residual FXN was approximately 5% of control levels, muscle mass was lower along with absolute grip strength. When we examined mechanisms that can affect muscle mass, only global protein translation was lower, accompanied by integrated stress response (ISR) activation. Also in mice, aerobic exercise training, initiated prior to the muscle mass difference, improved running capacity, yet, muscle mass and the ISR remained as in untrained mice. Thus, FXN loss can lead to lower lean mass, with ISR activation, both of which are insensitive to exercise training.

Authors

César Vásquez-Trincado, Julia Dunn, Ji In Han, Briyanna Hymms, Jaclyn Tamaroff, Monika Patel, Sara Nguyen, Anna Dedio, Kristin Wade, Chinazo Enigwe, Zuzana Nichtova, David R. Lynch, Gyorgy Csordas, Shana E. McCormack, Erin L. Seifert

×

Figure 6

FXN-depleted skeletal muscle exhibits alterations in mitochondrial function and morphology.

Options: View larger image (or click on image) Download as PowerPoint
FXN-depleted skeletal muscle exhibits alterations in mitochondrial funct...
All measurements were done in samples from WT and TG mice fed with Doxy for 18 weeks. (A) Oxygen consumption rate (JO2) measured in isolated skeletal muscle mitochondria supplied with pyruvate/malate (P/M; 10 mM/5 mM) or succinate (10 mM + 1 μM rotenone [S/R] to prevent electron backflow through complex I). Max oxphos: JO2 reflects maximal oxidative phosphorylation when saturating concentrations of ADP and substrate were used. Max nonphosphorylating: JO2 reflects maximal nonphosphorylating oxidation when oligomycin was used to inhibit the ATP synthase. Max ETC activity: JO2 reflects the maximal electron transport chain (ETC) activity for the prevailing substrate when the chemical uncoupler FCCP (1 μM) was used. (B) Left: Representative transmission electron microscopy images from EDL muscle showing mitochondria (arrows: mito), myofibrils (mf), and z lines (z). Upper panels: Scale bar: 2 μm. Lower panels: Scale bar: 500 nm. Right: Quantification of mitochondrial (mito) area (average mito area), mito area/skeletal muscle area, and abnormal mitos. Number of fields analyzed: 13–25 fields per sample, 35–125 mitos analyzed per field (total number of mitos per animal: 500–2500). (C) Left: Representative immunoblots of OPA1 (α-Tubulin: loading control). Major OPA1 forms are depicted by top, middle (mid), lower (low). Right: Average values of total OPA1 (OPA1tot)/α-Tub, top OPA1/OPA1tot, middle OPA1/ OPA1tot, and lower OPA1/ OPA1tot (n = 5/genotype). All panels: individual data points are shown, and bars represent mean ± SEM. Statistical comparison: unpaired t test, *P < 0.05, **P < 0.01.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts